Clinical Trial Update: Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nebulized heparin versus placebo for inhalation injury; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injury
• Inhalation Injury

Drugs mentioned

• Nebulized Heparin (unfractionated heparin)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Inhalation Injury, Burn Injury | Phase 3 | Status: TERMINATED